NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs
In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study
ACS Reorganization Plans, Policy Changes Discussed By Board
Society Support Program for Training Cytotechnologists
ACS Concludes That Laetrile Organization Is Insignificant
DeCosse: Colorectal Screening Could Save 6,000 Lives Per Year
NCI Plans Conference On DES Late Effects, Reproductive Cancers
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pam Bondi diagnosed with thyroid cancer









